ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dimethylformamide → 8-(6-(3,5-bis(trifluoromethyl)phenyl)benzo[d][1,3]dioxol-5-ylthio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine

HRID 521582
ノート
印刷プレビュー

反応式

HRID 521582 の反応式
[F:1][C:2]([F:17])([F:16])[C:3]1[CH:4]=[C:5](B(O)O)[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1.[CH3:18][CH:19]([NH:21][CH2:22][CH2:23][CH2:24][N:25]1[C:34]([S:35][C:36]2[CH:41]=[C:40]3[O:42][CH2:43][O:44][C:39]3=[CH:38][C:37]=2I)=[N:33][C:27]2[C:28]([NH2:32])=[N:29][CH:30]=[N:31][C:26]1=2)[CH3:20].C([O-])(O)=O.[Na+].CN(C=O)C>Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.O>[F:1][C:2]([F:17])([F:16])[C:3]1[CH:4]=[C:5]([C:37]2[C:36]([S:35][C:34]3[N:25]([CH2:24][CH2:23][CH2:22][NH:21][CH:19]([CH3:20])[CH3:18])[C:26]4[C:27]([N:33]=3)=[C:28]([NH2:32])[N:29]=[CH:30][N:31]=4)=[CH:41][C:40]3[O:42][CH2:43][O:44][C:39]=3[CH:38]=2)[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 6228DimethylformamideHCID 1562653,5-Bis-trifluoromethylphenylboronic acidHCID 516892Sodium BicarbonateHCID 9549213Zelavespib

生成物 1

HCID 872747508-(6-(3,5-bis(trifluoromethyl)phenyl)benzo[d][1,3]dioxol-5-ylthio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine

試薬・触媒・溶媒 2

HCID 178418476
HCID 178418476、化合物
触媒
HCID 962Water溶媒

反応条件

温度
90 °C

実験手順

3,5-Bis(trifluoromethyl)phenylboronic acid (22.6 mg, 0.0877 mmol) was added to PU-H71 (30 mg, 0.0585 mmol) and NaHCO3 (14.7 mg, 0.1755 mmol). DMF (0.5 mL) was added and the reaction mixture was evacuated and back filled with nitrogen. This was repeated four times then nitrogen was bubbled through the reaction mixture for 10 minutes. Then H2O (0.1 mL) and Pd(PPh3)2Cl2 (4 mg, 0.00584 mmol) were added and the reaction mixture was heated under nitrogen at 90° C. for 3 h. Solvent was removed under reduced pressure and the resulting residue was purified by preparatory TLC (hexane:CH2Cl2:EtOAc:MeOH—NH3 (7N), 4:5:2:1) to give 24.4 mg (70%) of DZ2-391. 1H NMR (500 MHz, CDCl3) δ 8.22 (s, 1H), 7.79 (s, 3H), 7.12 (s, 1H), 6.86 (s, 1H), 6.09 (s, 2H), 5.71 (br s, 2H), 4.07 (t, J=6.6 Hz, 2H), 2.82 (septet, J=6.2 Hz, 1H), 2.49 (t, J=6.5 Hz, 2H), 1.95 (m, 2H), 1.12 (d, J=6.3 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 154.1, 152.3, 151.5, 149.6, 148.6, 147.5, 142.1, 137.2, 131.2 (q, J=33 Hz), 129.6, 123.1 (q, J=270 Hz), 121.3, 119.6, 119.4, 114.9, 110.8, 102.4, 49.5, 42.8, 40.6, 28.8, 21.7; HRMS (ESI) m/z [M+H]+ calcd. for C26H25F6N6O2S, 599.1664; found. 599.1653; HPLC: method A Rt=7.45, method B Rt=9.38.

後処理

  1. customthe reaction mixture was evacuated
  2. additionback filled with nitrogen
  3. customnitrogen was bubbled through the reaction mixture for 10 minutes
  4. customSolvent was removed under reduced pressure
  5. customthe resulting residue was purified by preparatory TLC (hexane:CH2Cl2:EtOAc:MeOH—NH3 (7N), 4:5:2:1)
  6. customto give 24.4 mg (70%) of DZ2-391

出典と根拠

ORDレコード
ord-ac670ead7127415281e63d6f39473c76
出典データセット
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09328114B2

反応ノート

読み込み中…

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート